Invacare Corp (IVC) 20.68 $IVC
Invacare raises near-term capital with sale/leaseback deal
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 10:41AM CDT
IVC: 20.68 (+0.14)
Invacare concludes sale and leaseback deal in Ohio and Florida
M2 - Fri Apr 24, 5:53AM CDT
Medical products company Invacare (NYSE:IVC) said on Thursday that it has received USD23.0m in a sale and leaseback transaction under its ongoing plan to manage its capital structure.
IVC: 20.68 (+0.14)
Invacare Corporation Completes Sale and Leaseback Transaction
Business Wire - Thu Apr 23, 5:00PM CDT
As part of the Company's ongoing plan to manage its capital structure, Invacare Corporation (NYSE: IVC) announced today that it has secured $23.0 million in a sale and leaseback transaction. The Company sold and leased back under long-term leases, five of its properties located in Ohio and Florida. The net proceeds from the transaction will be used to reduce debt on the Company's revolving asset-based credit facility.
IVC: 20.68 (+0.14)
Invacare Corporation's (IVC) CEO Matthew Monaghan Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 11:28AM CDT
IVC: 20.68 (+0.14)
Invacare net loss improves in Q1
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 9:29AM CDT
IVC: 20.68 (+0.14)
Invacare Shares Up 22.2% Since SmarTrend's Buy Recommendation (IVC)
Comtex SmarTrend(R) - Thu Apr 23, 9:29AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 3 months, Invacare has returned 22.24% as of today's recent price of $21.13.
IVC: 20.68 (+0.14)
Invacare reports 1Q loss
Automated Insights - Thu Apr 23, 6:42AM CDT
ELYRIA, Ohio (AP) _ Invacare Corp. (IVC) on Thursday reported a loss of $7.3 million in its first quarter.
IVC: 20.68 (+0.14)
Invacare beats by $0.08, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:35AM CDT
IVC: 20.68 (+0.14)
Invacare Corporation Announces Financial Results for the First Quarter of 2015
Business Wire - Thu Apr 23, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the three months ended March 31, 2015.
IVC: 20.68 (+0.14)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)
Invacare reports tomorrow
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:21AM CDT
IVC: 20.68 (+0.14)
Medical Oxygen Systems - 2015 Global Strategic Business Report
M2 - Fri Apr 17, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3p22jk/medical_oxygen) has announced the addition of the "Medical Oxygen Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Oxygen Systems in US$ Thousands by the following Segments: Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 66 companies including many key and niche players such as: - Chart Industries, Inc. (US) - AirSep Corporation (US) - Chart SeQual Technologies, Inc. (US) - DeVilbiss Healthcare (US) - Inogen (US) - Inovo, Inc. (US) - Invacare Corporation (US) - Medical Gas Solutions (UK) - Philips Healthcare (US) - Terumo Corporation (Japan) - Weinmann Ger?te f?r Medizin GmbH Co. KG (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET GROWTH DRIVERS, TRENDS AND ISSUES 3. HOME OXYGEN THERAPY MARKET - A CLOSER LOOK 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 66 (including Divisions/Subsidiaries - 82) The United States (46) Canada (3) Japan (4) Europe (22) - France (3) - Germany (7) - The United Kingdom (
- Rest of Europe (4) Asia-Pacific (Excluding Japan) (6) Africa (1) For more information visit http://www.researchandmarkets.com/research/3p...cal_oxygen
IVC: 20.68 (+0.14), GTLS: 41.02 (+0.08)
IPO Stock Watch: Inogen Up On Analyst Affirmation
at Investor's Business Daily - Thu Apr 16, 4:06PM CDT
Medical equipment maker Inogen (INGN) jumped to a new high of 40.60 Thursday as the Street gained more clarity on an investigation into its accounting. On March 11, Inogen had put off its Q4 earnings report because "certain potential accounting...
PHG: 29.67 (+0.17), IVC: 20.68 (+0.14), INGN: 37.13 (+0.11), GTLS: 41.02 (+0.08)
Shares of IVC Up 15.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 15, 4:59PM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 15.65% as of today's recent price of $19.99.
IVC: 20.68 (+0.14)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.15 (-0.01), DHRM: 3.02 (-0.05), IVC: 20.68 (+0.14)
Invacare Corporation to Host Conference Call to Discuss First Quarter 2015 Financial Results
Business Wire - Tue Apr 14, 7:55AM CDT
Invacare Corporation (NYSE:IVC) ("Invacare" or the "Company"
announces that it will release its financial results for the first quarter 2015 before the market opens on Thursday, April 23, 2015. The Company will sponsor a conference call for investors and other interested parties on Thursday, April 23, at 8:30 AM ET to discuss the Company's performance.
IVC: 20.68 (+0.14)
13.1% Return Seen to Date on SmarTrend Invacare Call (IVC)
Comtex SmarTrend(R) - Wed Apr 08, 11:33AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 13.10% as of today's recent price of $19.55.
IVC: 20.68 (+0.14)
Uptrend Call Working As Invacare Stock Rises 13.5% (IVC)
Comtex SmarTrend(R) - Tue Mar 24, 9:44AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 13.45% as of today's recent price of $19.61.
IVC: 20.68 (+0.14)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 10.02 (+0.19), ILMN: 189.59 (-3.01), HBIO: 6.22 (+0.08), PODD: 30.72 (+0.11), IART: 61.31 (+0.84), IVC: 20.68 (+0.14), IMRS: 0.69 (+0.04), INGN: 37.13 (+0.11), IDXX: 164.05 (+4.65), HRC: 51.94 (+0.03), HOLX: 33.99 (+0.57)
Potent groups take sides on bipartisan House Medicare plan
By ALAN FRAM - AP - Sat Mar 21, 3:18PM CDT
WASHINGTON (AP) — A budding bipartisan deal to shelter physicians from Medicare cuts, championed by the House's two top leaders, is drawing powerful allies including the American Medical Association and a rainbow of conservative and liberal groups.
IVC: 20.68 (+0.14)
Invacare raises near-term capital with sale/leaseback deal
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 10:41AM CDT
IVC: 20.68 (+0.14)
Invacare concludes sale and leaseback deal in Ohio and Florida
M2 - Fri Apr 24, 5:53AM CDT
Medical products company Invacare (NYSE:IVC) said on Thursday that it has received USD23.0m in a sale and leaseback transaction under its ongoing plan to manage its capital structure.
IVC: 20.68 (+0.14)
Invacare Corporation Completes Sale and Leaseback Transaction
Business Wire - Thu Apr 23, 5:00PM CDT
As part of the Company's ongoing plan to manage its capital structure, Invacare Corporation (NYSE: IVC) announced today that it has secured $23.0 million in a sale and leaseback transaction. The Company sold and leased back under long-term leases, five of its properties located in Ohio and Florida. The net proceeds from the transaction will be used to reduce debt on the Company's revolving asset-based credit facility.
IVC: 20.68 (+0.14)
Invacare Corporation's (IVC) CEO Matthew Monaghan Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 11:28AM CDT
IVC: 20.68 (+0.14)
Invacare net loss improves in Q1
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 9:29AM CDT
IVC: 20.68 (+0.14)
Invacare Shares Up 22.2% Since SmarTrend's Buy Recommendation (IVC)
Comtex SmarTrend(R) - Thu Apr 23, 9:29AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 3 months, Invacare has returned 22.24% as of today's recent price of $21.13.
IVC: 20.68 (+0.14)
Invacare reports 1Q loss
Automated Insights - Thu Apr 23, 6:42AM CDT
ELYRIA, Ohio (AP) _ Invacare Corp. (IVC) on Thursday reported a loss of $7.3 million in its first quarter.
IVC: 20.68 (+0.14)
Invacare beats by $0.08, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:35AM CDT
IVC: 20.68 (+0.14)
Invacare Corporation Announces Financial Results for the First Quarter of 2015
Business Wire - Thu Apr 23, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the three months ended March 31, 2015.
IVC: 20.68 (+0.14)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)
Invacare reports tomorrow
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:21AM CDT
IVC: 20.68 (+0.14)
Medical Oxygen Systems - 2015 Global Strategic Business Report
M2 - Fri Apr 17, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3p22jk/medical_oxygen) has announced the addition of the "Medical Oxygen Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Oxygen Systems in US$ Thousands by the following Segments: Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 66 companies including many key and niche players such as: - Chart Industries, Inc. (US) - AirSep Corporation (US) - Chart SeQual Technologies, Inc. (US) - DeVilbiss Healthcare (US) - Inogen (US) - Inovo, Inc. (US) - Invacare Corporation (US) - Medical Gas Solutions (UK) - Philips Healthcare (US) - Terumo Corporation (Japan) - Weinmann Ger?te f?r Medizin GmbH Co. KG (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET GROWTH DRIVERS, TRENDS AND ISSUES 3. HOME OXYGEN THERAPY MARKET - A CLOSER LOOK 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 66 (including Divisions/Subsidiaries - 82) The United States (46) Canada (3) Japan (4) Europe (22) - France (3) - Germany (7) - The United Kingdom (
- Rest of Europe (4) Asia-Pacific (Excluding Japan) (6) Africa (1) For more information visit http://www.researchandmarkets.com/research/3p...cal_oxygen IVC: 20.68 (+0.14), GTLS: 41.02 (+0.08)
IPO Stock Watch: Inogen Up On Analyst Affirmation
at Investor's Business Daily - Thu Apr 16, 4:06PM CDT
Medical equipment maker Inogen (INGN) jumped to a new high of 40.60 Thursday as the Street gained more clarity on an investigation into its accounting. On March 11, Inogen had put off its Q4 earnings report because "certain potential accounting...
PHG: 29.67 (+0.17), IVC: 20.68 (+0.14), INGN: 37.13 (+0.11), GTLS: 41.02 (+0.08)
Shares of IVC Up 15.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 15, 4:59PM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 15.65% as of today's recent price of $19.99.
IVC: 20.68 (+0.14)
Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 42.15 (-0.01), DHRM: 3.02 (-0.05), IVC: 20.68 (+0.14)
Invacare Corporation to Host Conference Call to Discuss First Quarter 2015 Financial Results
Business Wire - Tue Apr 14, 7:55AM CDT
Invacare Corporation (NYSE:IVC) ("Invacare" or the "Company"
announces that it will release its financial results for the first quarter 2015 before the market opens on Thursday, April 23, 2015. The Company will sponsor a conference call for investors and other interested parties on Thursday, April 23, at 8:30 AM ET to discuss the Company's performance. IVC: 20.68 (+0.14)
13.1% Return Seen to Date on SmarTrend Invacare Call (IVC)
Comtex SmarTrend(R) - Wed Apr 08, 11:33AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 13.10% as of today's recent price of $19.55.
IVC: 20.68 (+0.14)
Uptrend Call Working As Invacare Stock Rises 13.5% (IVC)
Comtex SmarTrend(R) - Tue Mar 24, 9:44AM CDT
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on February 6th, 2015 at $17.29. In approximately 2 months, Invacare has returned 13.45% as of today's recent price of $19.61.
IVC: 20.68 (+0.14)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 10.02 (+0.19), ILMN: 189.59 (-3.01), HBIO: 6.22 (+0.08), PODD: 30.72 (+0.11), IART: 61.31 (+0.84), IVC: 20.68 (+0.14), IMRS: 0.69 (+0.04), INGN: 37.13 (+0.11), IDXX: 164.05 (+4.65), HRC: 51.94 (+0.03), HOLX: 33.99 (+0.57)
Potent groups take sides on bipartisan House Medicare plan
By ALAN FRAM - AP - Sat Mar 21, 3:18PM CDT
WASHINGTON (AP) — A budding bipartisan deal to shelter physicians from Medicare cuts, championed by the House's two top leaders, is drawing powerful allies including the American Medical Association and a rainbow of conservative and liberal groups.
IVC: 20.68 (+0.14)
